PL3278811T3 - Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych - Google Patents

Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych

Info

Publication number
PL3278811T3
PL3278811T3 PL17187879T PL17187879T PL3278811T3 PL 3278811 T3 PL3278811 T3 PL 3278811T3 PL 17187879 T PL17187879 T PL 17187879T PL 17187879 T PL17187879 T PL 17187879T PL 3278811 T3 PL3278811 T3 PL 3278811T3
Authority
PL
Poland
Prior art keywords
ggf2
neuropathic pain
peripheral nerve
nerve injury
treat neuropathic
Prior art date
Application number
PL17187879T
Other languages
English (en)
Inventor
Anthony O. Caggiano
Anthony J. Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics, Inc. filed Critical Acorda Therapeutics, Inc.
Publication of PL3278811T3 publication Critical patent/PL3278811T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL17187879T 2012-03-30 2013-03-29 Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych PL3278811T3 (pl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
EP17187879.6A EP3278811B1 (en) 2012-03-30 2013-03-29 Use of ggf2 to treat neuropathic pain upon peripheral nerve injury
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury
EP13716919.9A EP2830645B1 (en) 2012-03-30 2013-03-29 Neuregulin for use in treating peripheral nerve injury

Publications (1)

Publication Number Publication Date
PL3278811T3 true PL3278811T3 (pl) 2021-08-02

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13716919T PL2830645T3 (pl) 2012-03-30 2013-03-29 Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego
PL17187879T PL3278811T3 (pl) 2012-03-30 2013-03-29 Zastosowanie ggf2 do leczenia bólu neuropatycznego po urazie nerwów obwodowych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13716919T PL2830645T3 (pl) 2012-03-30 2013-03-29 Neuregulina do zastosowania w leczeniu uszkodzenia nerwu obwodowego

Country Status (15)

Country Link
US (3) US20150094263A1 (pl)
EP (3) EP3278811B1 (pl)
JP (4) JP6420233B2 (pl)
CN (2) CN104321072A (pl)
AU (4) AU2013237896B2 (pl)
BR (1) BR112014024308B1 (pl)
CA (1) CA2869070A1 (pl)
DK (2) DK3278811T3 (pl)
ES (2) ES2647917T3 (pl)
IL (3) IL288785B2 (pl)
MX (1) MX354598B (pl)
NZ (1) NZ700546A (pl)
PL (2) PL2830645T3 (pl)
PT (2) PT3278811T (pl)
WO (1) WO2013149163A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166068A1 (en) 2008-07-17 2011-07-07 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure
BR112012008821A2 (pt) 2009-10-14 2020-09-15 Acorda Therapeutics, Inc. uso de neuregulina para tratar lesões nervosas periféricas.
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
WO2017096358A1 (en) * 2015-12-04 2017-06-08 University Of Iowa Research Foundation Apparatus, systems and methods for predicting, screening and monitoring of encephalopathy / delirium
US11511136B2 (en) 2017-11-17 2022-11-29 The Research Foundation For The State University Of New York Method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
CA3149371A1 (en) * 2019-08-01 2021-02-04 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US888A (en) 1838-08-20 perkins
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
EP1028735A4 (en) * 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
ES2610353T3 (es) * 2000-05-23 2017-04-27 Cenes Pharmaceuticals, Inc. Moléculas de ácido nucleico NRG-2, polipéptidos y métodos diagnósticos y terapéuticos
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
US8410050B2 (en) * 2008-02-29 2013-04-02 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
US20110166068A1 (en) * 2008-07-17 2011-07-07 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure
KR101237927B1 (ko) * 2009-05-07 2013-03-04 (주)문엔제이 신경손상 및 신경질환 예방 또는 치료용 약학조성물
BR112012008821A2 (pt) * 2009-10-14 2020-09-15 Acorda Therapeutics, Inc. uso de neuregulina para tratar lesões nervosas periféricas.
CA2845198A1 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
HK1249038A1 (en) 2018-10-26
DK2830645T3 (da) 2017-11-20
EP3278811A1 (en) 2018-02-07
US20150094263A1 (en) 2015-04-02
HK1206632A1 (en) 2016-01-15
JP7108724B2 (ja) 2022-07-28
IL288785B2 (en) 2023-03-01
AU2020260539A1 (en) 2020-11-26
BR112014024308A8 (pt) 2018-01-23
AU2019202401A1 (en) 2019-05-02
EP3278811B1 (en) 2020-12-02
US20160346353A1 (en) 2016-12-01
JP2017149746A (ja) 2017-08-31
EP2830645B1 (en) 2017-08-30
BR112014024308B1 (pt) 2021-11-30
DK3278811T3 (da) 2021-03-01
PT3278811T (pt) 2021-03-03
IL273186A (en) 2020-04-30
AU2018200592A1 (en) 2018-02-15
PL2830645T3 (pl) 2018-01-31
JP2019131582A (ja) 2019-08-08
AU2019202401B2 (en) 2020-10-15
JP6420233B2 (ja) 2018-11-07
BR112014024308A2 (pt) 2017-08-08
MX354598B (es) 2018-03-12
IL288785A (en) 2022-02-01
US20230117985A1 (en) 2023-04-20
EP2830645A1 (en) 2015-02-04
AU2013237896B2 (en) 2017-11-02
IL234882B (en) 2020-03-31
IL288785B (en) 2022-11-01
ES2857810T3 (es) 2021-09-29
CA2869070A1 (en) 2013-10-03
AU2013237896A1 (en) 2014-10-16
PT2830645T (pt) 2017-11-28
WO2013149163A1 (en) 2013-10-03
IL234882A0 (en) 2014-12-31
JP2021059605A (ja) 2021-04-15
JP2015514096A (ja) 2015-05-18
CN106511971A (zh) 2017-03-22
EP3842059A1 (en) 2021-06-30
CN104321072A (zh) 2015-01-28
NZ700546A (en) 2017-05-26
MX2014011838A (es) 2015-03-09
ES2647917T3 (es) 2017-12-27
IL273186B (en) 2022-01-01

Similar Documents

Publication Publication Date Title
IL281833A (en) Treatment of AMD with AAV SFLT-1
IL266159A (en) Treatment of circadian rhythm disorders
IL233714A0 (en) Treatment of diseases related to the circadian rhythm
PT2879672T (pt) Terapia combinada para o tratamento da esclerose múltipla
PT3278811T (pt) Utilização de ggf2 para tratar dor neuropática por lesão do nervo periférico
EP2675460A4 (en) TREATMENT OF FAT TISSUE UNDER CHIN
EP2869833A4 (en) TREATMENT OF INFLAMMATORY SKIN DISORDERS
GB201506561D0 (en) Treatment of amblyopia
IL235984A0 (en) Causes prophylactic and/or medical treatment of peripheral neuropathic pain caused by an anticancer drug
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
IL239429A0 (en) Use of fidotimide to treat psoriasis
GB201107467D0 (en) Novel treatment of pain
EP2892612B8 (en) Device for non-invasive vagal nerve stimulation to treat disorders
GB201208505D0 (en) Treatment of skin condition
GB201208503D0 (en) Treatment of a skin condition